GENEDX HOLDINGS (WGS)
(Delayed Data from NSDQ)
$28.00 USD
+0.24 (0.86%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $28.04 +0.04 (0.14%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
WGS 28.00 +0.24(0.86%)
Will WGS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for WGS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WGS
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Tops Revenue Estimates
Take the Zacks Approach to Beat the Market: Virtu, Coinbase, General Mills in Focus
WGS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why GENEDX HOLDINGS (WGS) Could be Great Choice for a Bottom Fisher
Bears are Losing Control Over GeneDx Holdings Corp. (WGS), Here's Why It's a 'Buy' Now
PacBio (PACB) Inks Research Collaboration for Genome Sequencing
Other News for WGS
The Latest Analyst Ratings For GeneDx Hldgs
GeneDx price target raised by $16 at BTIG, here's why
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
GeneDx announces collaboration with Epic Aura
Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying